FDA Approves Tazverik, First Drug for Rare Sarcoma

  • Gary Schwartz

Press/Media

Period24 Jan 2020

Media coverage

4

Media coverage

  • TitleFDA Approves Tazverik, First Drug for Rare Sarcoma
    Media name/outletSeminars In Respiratory and Critical Care Medicine
    Country/TerritoryUnited States
    Date24/01/20
    URLwww.medscape.com/viewarticle/924204?src=rss
    PersonsGary Schwartz
  • TitleFDA Approves Tazemetostat ( Tazverik ), First Drug for Rare Sarcoma
    Media name/outletSeminars In Respiratory and Critical Care Medicine
    Country/TerritoryUnited States
    Date24/01/20
    URLwww.medscape.com/viewarticle/924204?src=rss
    PersonsGary Schwartz
  • TitleFDA Approves Tazemetostat, First Drug for Rare Sarcoma
    Media name/outletSeminars In Respiratory and Critical Care Medicine
    Country/TerritoryUnited States
    Date24/01/20
    URLwww.medscape.com/viewarticle/924204?src=rss
    PersonsGary Schwartz
  • TitleFDA Approves Tazverik, First Drug for Rare Sarcoma
    Media name/outletMedscape eMedicine
    Country/TerritoryUnited States
    Date24/01/20
    URLhttps://www.medscape.com/viewarticle/924204
    PersonsGary Schwartz